Hypogastric Plexus Block: Technique, Indications, and Clinical Pearls

The superior hypogastric plexus (SHP) is a retroperitoneal neural network at the L5-S1 vertebral level (promontory of sacrum), anterior to the sacral promontory and bifurcation of the common iliac arteries. It carries sympathetic (T10-L2) and visceral afferent fibers from pelvic viscera (bladder, uterus, prostate, rectum, distal colon) and lower ureters. A hypogastric plexus block (HPB) interrupts this transmission, providing visceral pelvic pain relief.

Anatomy & Target

  • Location: Retroperitoneal, midline, anterior to L5-S1 disc space/sacral promontory, between common iliac arteries.
  • Fibers: Sympathetic (T10-L2) + visceral afferents (pelvic organs). Parasympathetic (S2-S4) via pelvic splanchnics — NOT blocked by HPB.

Indications

  • Malignant pelvic pain: Cervical, endometrial, ovarian, rectal, prostate, bladder cancers. Often refractory to opioids.
  • Benign chronic pelvic pain: Endometriosis, interstitial cystitis/painful bladder syndrome, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), vulvodynia, post-surgical neuralgia.
  • Acute visceral pain: Pancreatitis (celiac plexus more common), mesenteric ischemia, postoperative ileus (sympathetic blockade enhances motility).

Technique: Fluoroscopic or CT-Guided (Transdiscal/Paradiscal)

  1. Prone, mild sedation, monitors.
  2. Fluoroscopy: AP view, L5-S1 disc space identified. Needle (22G spinal/Chiba) advanced to anterior L5-S1 disc space (transdiscal) or just lateral (paradiscal).
  3. Contrast injection: Confirms pre-sacral spread (linear, cephalad-caudad along promontory), not vascular or intradiscal.
  4. Neurolytic: 6-10 mL 50% alcohol or 6% phenol (malignant pain). Diagnostic/therapeutic: 10-20 mL 0.25% bupivacaine ± steroid.
  5. CT guidance offers better soft tissue visualization, avoids disc puncture.

Alternative Approaches

  • Transsacral (caudal): Via sacral hiatus, advanced intracranally to SHP. Less common.
  • Endoscopic (laparoscopic): Direct visualization during pelvic surgery.
  • Radiofrequency ablation (RFA): Pulsed or thermal RFA of SHP for longer duration (6-12 months).

Expected Block Distribution

  • Visceral analgesia: Pelvic organs (uterus, bladder, prostate, rectum, distal colon).
  • Somatic sparing: No motor/sensory block of lower extremities (distinguishes from epidural/caudal).
  • Sympathetic signs: Warmth, dryness in perineum; possible transient hypotension.

Complications

  • Disc injury/infection (transdiscal approach).
  • Vascular injury (iliac vessels, median sacral artery).
  • Neurologic: Somatic nerve root injury (L5/S1), femoral nerve (rare).
  • Retroperitoneal hematoma.
  • Transient hypotension (sympathetic blockade).
  • Neurolytic: Genitofemoral neuralgia, paraplegia (extremely rare, artery of Adamkiewicz).

Contraindications

  • Coagulopathy (INR >1.5, platelets <50k, therapeutic anticoagulation).
  • Local/systemic infection.
  • Bowel obstruction/perforation.
  • Allergy to contrast/local anesthetic/neurolytic.

Clinical Pearls

  • Diagnostic block with local anesthetic before neurolysis — confirms target and predicts benefit.
  • Combine with celiac plexus block for upper abdominal + pelvic pain (e.g., pancreatic cancer with pelvic mets).
  • Patient selection: Visceral pain (dull, diffuse, midline) responds better than somatic/neuropathic.
  • Multimodal: HPB + medications (gabapentinoids, antidepressants) + PT + psychosocial support.

HPB is a specialized interventional tool for refractory visceral pelvic pain. Precision imaging, careful patient selection, and integration into comprehensive pain management yield the best outcomes.

Huna Hypnotherapy - Related Articles